ORMP · Forms 3, 4, 5
Insider trades at ORAMED PHARMACEUTICALS INC.
2 insiders sold $226K of ORAMED PHARMACEUTICALS INC. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for ORAMED PHARMACEUTICALS INC. (ORMP) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Avraham Gabay | Chief Financial Officer | Sell (10b5-1 plan) | 20,000 | $4.51 | $90K | Form 4 | |
| Joshua Hexter | COO & CBO | Sell (10b5-1 plan) | 30,000 | $4.51 | $135K | Form 4 | |
| Nadav Kidron | President and CEO | Award | 349,497 | Form 4 | |||
| Nadav Kidron | President and CEO | Award | 368,765 | Form 4 | |||
| Joshua Hexter | COO & CBO | Award | 75,455 | Form 4 | |||
| Joshua Hexter | COO & CBO | Award | 209,291 | Form 4 | |||
| Miriam Kidron | Chief Scientific Officer | Award | 208,125 | Form 4 | |||
| Miriam Kidron | Chief Scientific Officer | Award | 209,291 | Form 4 | |||
| Avraham Gabay | Chief Financial Officer | Award | 209,291 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.